Biomedical Engineering Reference
In-Depth Information
39. Schwab ED, Pienta KJ. 1997. Modeling signal transduction in normal and cancer cells using
complex adaptive systems. Med Hypotheses 48 :111-123.
40. Holland J. 1995. Hidden order: how adaptation builds complexity . Addison-Wesley, New
York.
41. Chinnaiyan AM, Coffey DS, Forrest S, Goldberg E, Holland J, Kepler T, Maley C, Mitchell M,
Montie JE, Morowitz M, Nelson WG, Omenn G, Perelson AS, Pienta KJ, Rubin MA, Scardino
P, Shapiro JA, Wheeler T. 2002. Merging bottom-up and top-down approaches to study pros-
tate cancer biology. Complexity 7 :22-30.
42. Kauffman SA. 1991. Antichaos and adaptation. Sci Am 265 :78-84.
43. Pienta KJ, Murphy BC, Getzenberg RH, Coffey DS. 1993. The tissue matrix and the regulation
of gene expression in cancer cells. Adv Mol Cell Biol 7 :131-156.
44. Temin HM. 1988. Evolution of cancer genes as a mutation-driven process. Cancer Res
48 :1697-1701.
45. Lewin RS. 1993. Complexity: life at the edge of chaos . Collier Books, New York.
46. Bao JZ, Davis CC, Schmukler RE. 1993. Impedance spectroscopy of human erythrocytes:
system calibration and nonlinear modeling. IEEE Trans Biomed Eng 40 :364-378.
47. Semenza GL. 2003. Targeting HIF-1 for cancer therapy. Nature Rev Cancer . 3 :721-732.
48. Kerr RA. 2002. Evolution: a trigger for the Cambrian explosion? Science 298 :1547.
49. Lupold SE, Hicke BJ, Lin Y, Coffey DS. 2002. Identification and characterization of nuclease-
stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific mem-
brane antigen. Cancer Res 62 :4029-4033.
50. Coffey DS. 2002. Understanding the cancer biology universe: enigmas, context and future
prospects. Cancer Biol Ther 1 :564-567.
51. Faria M, Ulrich H. 2002. The use of synthetic oligonucleotides as protein inhibitors and anti-
code drugs in cancer therapy: accomplishments and limitations. Curr Cancer Drug Targets
2 :355-368.
52. Cerchia L, Hamm J, Libri D, Tavitian B, de Franciscis V. 2002. Nucleic acid aptamers in can-
cer medicine. FEBS Lett 528 :12-16.
53. Lato SM, Ozerova ND, He K, Sergueeva Z, Shaw BR, Burke DH. 2002. Boron-containing
aptamers to ATP. Nucleic Acids Res 30 :1401-1407.
54. Tuerk C, Gold L. 1990. Systematic evolution of ligands by exponential enrichment: RNA
ligands to bacteriophage T4 DNA polymerase. Science 249 (4968):505-510.
55.
Hicke BJ, Marion C, Chang YF, Gould T, Lynott CK, Parma D, Schmidt PG, Warren S. 2001.
Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem
276:48644-48654.
Search WWH ::




Custom Search